Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma
一项评估simlukafusp alfa (FAP-IL2v)联合atezolizumab治疗复发性和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的II期研究
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2024.105374
Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Guerra Alia, Eva Maria; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R; Deva, Sanjeev; Taus, Álvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Roselló-Keränen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgräber, Volker; Keshelava, Nino; Dziadziuszko, Rafal